Rosacea, Erythematotelangiectatic
Conditions
Keywords
Nd:YAG laser
Brief summary
The goal of this clinical study is to assess the effectiveness of Nd:YAG laser 1064 nm in the long pulse mode in the treatment of signs of rosacea including the erythema of the face and telangiectasia. The used parameter of this laser was of very low energy (spot size: 5mm, fluence: 4.07 J/Cm2, energy: 800 millijoules (mJ) and frequency: 5 Hz. About 2-3 passes performed in each treatment session. Up to four sessions were performed for each patient with 2 weeks interval) and also its was expected to have minimal adverse effects.
Interventions
DEVICENd:YAG laser 1064 nm
The entire face of each patient with rosacea was treated with long-pulse 1064nm Nd:YAG laser. The parameters that been used were spot size: 5mm, fluence: 4.07 J/Cm2, energy: 800 mJ and frequency: 5 Hz. About 2-3 passes performed in each treatment session. Up to four sessions were performed for each patient with 2 weeks interval.
Sponsors
Hawler Medical University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
32 Years to 52 Years
Healthy volunteers
No
Inclusion criteria
* Patient with rosacea (erythemato-telangiectatic type)
Exclusion criteria
* Other clinical types of rosacea * Pregnancy and lactation in females * History of malignancies * History of photosensitivity * History of any other modalities of treatment of rosacea over last 6 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in erythema of face of patients with rosacea been treated by ND:YAG laser 1064 nm long pulse width by using clinician erythema scale (CEA) | Three months | Erythema was graded from 0 to 4 using clinician erythema assessment scale (CEA). The score 0 is the lowest score of erythema and score 4 means the highest severity of erythema of the skin |
Countries
Iraq
Outcome results
None listed